Introducing NACI newest recommendations regarding the use of Hepatitis B vaccine

Canada
29 March 2017

NACI have released the update on the recommended use of Hepatitis B vaccine. It includes 4 main recommendations:

  1. NACI does not recommend routine booster doses of HB vaccine for immunocompetent individuals following the completion of a recommended HB immunization schedule given in infancy.
  2. NACI recommends that adults with diabetes need not be considered as a separate high risk group for immunization with HB vaccine.
  3. For immunocompromised individuals, initial annual monitoring of HB antibody levels following HB immunization may be considered
  4. Immunization with HB-containing vaccine should be provided according to determined provincial and territorial (P/T) schedules.

ca.png
Documents to download

Related News & Events

  • Canada

    NACI mandate expands to support local decision-making on vaccine programs

    28.07.2017

    In June 2016 the Public Health Agency of Canada (PHAC) announced that the mandate of Canada’s NITAG, the National Advisory Committee on Immunization (NACI) will be expanded. In addition to the assessment of vaccine characteristics (safety, efficacy, effectiveness, and immunogenicity), NACI will also be assessing additional programmatic elements including economic evaluations, feasibility of implementation, acceptability, ethics and equity. 

    Read more
  • Belgium
    SAGE

    New advisory report for the vaccination against Tick-Borne Encephalitis

    21.03.2019

    The Superior Health Council (SHC) received 2 requests for an advisory report by letter, on May 12 2017 from the Risk Management Group (FPS Health, Food Chain Safety and Environment) and on November 14 2018 from the federal Minister of Health. Both requests are treated in this advisory report.
     

    Read more
  • 2 -4
    April
    Switzerland
    SAGE

    SAGE Meeting

    WHO
    Geneva